This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Merck Serono S. a.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: H James Brentzel, Jr: Innovator in Multiple Sclerosis Treatment
Introduction
H James Brentzel, Jr. is a notable inventor based in Marshfield, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis. With a total of 3 patents to his name, Brentzel's work has the potential to impact many lives.
Latest Patents
One of his latest patents focuses on a Cladribine regimen for treating multiple sclerosis. This invention relates to the use of multiple doses of Cladribine combined with beta interferon for the treatment of multiple sclerosis in patients who are refractory to at least one conventional therapy. This innovative approach aims to provide new hope for patients who have not responded to traditional treatments.
Career Highlights
Brentzel is currently associated with Merck Serono S. A., a leading company in the pharmaceutical industry. His work at Merck Serono has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Maria Lopez-Bresnahan and Nazih Ammoury. Their combined expertise enhances the innovative environment at Merck Serono, fostering advancements in medical treatments.
Conclusion
H James Brentzel, Jr. is a dedicated inventor whose work in multiple sclerosis treatment exemplifies the impact of innovation in healthcare. His contributions continue to pave the way for new therapeutic options for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile